The series A capital will support construction of a cellular production plant in China for the pharmaceutical services provider.
Month: January 2019
Syqe Medical inhales $50m
Martin Bauer’s PRM Holdings unit has contributed to a round that will help Syqe expand use of its medical cannabis inhaler to other substances.
Iota attends to $15m series A
Astellas chipped in as UC Berkeley spinout Iota Biosciences captured $15m in a series A round that will fund the entry of its neural dust technology into preclinical testing.
NuoDB nets $30m in new funding
The database software provider reportedly boosted its total funding to $95m in a Temenos-led round that included existing investor Dassault Systèmes.
Itochu kicks off Promethera’s series D round
Promethera Biosciences has received $11.3m in series D funding from Itochu and $16.6m in a convertible debt round backed by Sosei.
ABC Technology assembles $30m round
The financial analysis software provider, which counts SIG as an investor, has secured series B funding to take its overall funding to date to $60m.
SonicAI tunes in to $29m series B
The Baidu-backed acoustics technology developer has raised money in an Addor Capital-led round that reportedly boosted its overall funding to $86m.
Singapore Life attracts $20m from Aflac
Aflac has invested $20m in the life insurance portal in connection with a reinsurance services agreement, following a $50m series A round in 2017.
Sight Diagnostics snags $28m
The blood-testing device producer, which counts Access Industries and Haisco as investors, has added $28m to its coffers.
Vedanta steadies $27m series C
Bristol-Myers Squibb and PureTech Health both backed a round that followed the $50m that PureTech spinoff Vedanta secured in 2016.
Blackbuck racks up new funding
The Flipkart-backed shipping services platform has raised additional capital from Accel and Sands Capital, taking its total funding to approximately $141m.
Futu files for $300m IPO
Tencent owns a 38% stake in the online brokerage, which has filed to go public in the US with a smaller target than previously reported.
Antengene generates $120m in series B round
Celgene, Taikang and WuXi AppTec have all taken part in a series B round for Antengene, which is working on treatments for cancers with a focus on Southeast and East Asia.
Bakkt attracts corporates for nine-figure round
Bakkt, a digital asset exchange formed by Intercontinental Exchange, received approximately $183m from investors including Microsoft, PayU and Boston Consulting Group.